Abstract | BACKGROUND: STUDY DESIGN: Long-term follow-up of study B of the MDRD Study (1989-1993). SETTING & PARTICIPANTS: INTERVENTION: OUTCOMES: RESULTS:
Kidney failure developed in 227 (89%) participants, 79 (30.9%) died, and 244 (95.7%) reached the composite outcome of either kidney failure or death. Median duration of follow-up until kidney failure, death, or administrative censoring was 3.2 years, and median time to death was 10.6 years. In the low- protein group, 117 (90.7%) participants developed kidney failure, 30 (23.3%) died, and 124 (96.1%) reached the composite outcome. In the very low- protein group, 110 (87.3%) participants developed kidney failure, 49 (38.9%) died, and 120 (95.2%) reached the composite outcome. After adjustment for a priori-specified covariates, hazard ratios were 0.83 (95% confidence interval, 0.62 to 1.12) for kidney failure, 1.92 (95% confidence interval, 1.15 to 3.20) for death, and 0.89 (95% confidence interval, 0.67 to 1.18) for the composite outcome in the very low-protein diet group compared with the low-protein diet group. LIMITATIONS: CONCLUSION: In long-term follow-up of the MDRD Study, assignment to a very low-protein diet did not delay progression to kidney failure, but appeared to increase the risk of death.
|
Authors | Vandana Menon, Joel D Kopple, Xuelei Wang, Gerald J Beck, Allan J Collins, John W Kusek, Tom Greene, Andrew S Levey, Mark J Sarnak |
Journal | American journal of kidney diseases : the official journal of the National Kidney Foundation
(Am J Kidney Dis)
Vol. 53
Issue 2
Pg. 208-17
(Feb 2009)
ISSN: 1523-6838 [Electronic] United States |
PMID | 18950911
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
|
Topics |
- Adult
- Amino Acids
(administration & dosage)
- Chronic Disease
- Diet, Protein-Restricted
- Dietary Supplements
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Keto Acids
(administration & dosage)
- Kidney Diseases
(diet therapy)
- Male
- Randomized Controlled Trials as Topic
- Renal Insufficiency
(mortality, prevention & control)
- Survival Analysis
|